Remove Antibody Remove Manufacturing Remove Recombinant Antibody Remove Regulation
article thumbnail

Purolite and Repligen to commercially launch novel CH1 affinity resin

BioPharma Reporter

Ion exchange resin manufacturer Purolite and bioprocessing technology firm Repligen have announced the commercial launch of Praesto CH1, an affinity resin designed to purify specialized mAbs such as bispecifics and recombinant antibody fragments.